Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis

scientific article published on February 1984

Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/INFDIS/149.2.257
P698PubMed publication ID6421944

P2093author name stringLerner AM
Reyes MP
Tablan OC
Rintelmann WF
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectgentamicinQ422482
P304page(s)257-263
P577publication date1984-02-01
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleRenal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis
P478volume149

Reverse relations

cites work (P2860)
Q28316869A comparison of netilmicin and tobramycin therapy in patients with renal impairment
Q33714230Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials
Q41148557Advances in medical and antibiotic management of infective endocarditis
Q82519004Aminoglycoside induced nephrotoxicity: molecular modeling studies of calreticulin-gentamicin complex
Q38676819Aminoglycoside-induced hearing loss in humans
Q40423331Antibiotic therapy and the anesthesiologist
Q98170152Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis
Q33429288Antimicrobial therapy for pediatric patients
Q46417990Audiologic testing and molecular analysis of 12S rRNA in patients receiving aminoglycosides
Q50193219Drug-Induced Ototoxicity: Diagnosis and Monitoring.
Q37687045Inhibition of ARC decreases the survival of HEI-OC-1 cells after neomycin damage in vitro
Q40022701Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination
Q34130045Monotherapy versus combination therapy for bacterial infections.
Q35752292NaHS Protects Cochlear Hair Cells from Gentamicin-Induced Ototoxicity by Inhibiting the Mitochondrial Apoptosis Pathway
Q54200566Piperacillin/tazobactam in the treatment of polymicrobial infections.
Q40949882Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy
Q35908254Presence of tobramycin in blood and urine during selective decontamination of the digestive tract in critically ill patients, a prospective cohort study
Q38070006Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).
Q28596353Reduced TRMU expression increases the sensitivity of hair-cell-like HEI-OC-1 cells to neomycin damage in vitro
Q35642347Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans
Q40196347Serum level monitoring of antibacterial drugs. A review
Q28361967Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides

Search more.